Baker Bros Advisors LP

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Kodiak Sciences Inc.
KOD
$91.05M32.9517.31M0%+$01.14
Sanara MedTech Inc.
SMTI
$23.81M27.612.38MNew+$23.81M0.3
ACADIA Pharmaceuticals Inc.
ACAD
$792.57M25.9442.86M0%+$09.95
Prelude Therapeutics Incorporated
PRLD
$47.99M18.4310.12M0%+$00.6
Sera Prognostics, Inc.
SERA
$49.45M16.645.43M0%+$00.62
Incyte Corporation
INCY
$2.06B16.1136.18M+<0.01%+$30,934.7125.89
Replimune Group, Inc.
REPL
$77.99M15.549.55M0%+$00.98
Entrada Therapeutics, Inc.
TRDA
$68.95M14.414.87M0%+$00.87
Bicycle Therapeutics plc
BCYC
$123.08M11.554.94M+176.07%+$78.5M1.55
Cerus Corporation
CERS
$36.81M10.5419.48M0%+$00.46
Rhythm Pharmaceuticals, Inc.
RYTM
$277.24M10.496.4M0%+$03.48
Kymera Therapeutics, Inc.
KYMR
$241.04M9.776M0%+$03.03
AbCellera Biologics Inc.
ABCL
$124.69M9.3627.53M+20.15%+$20.91M1.57
Madrigal Pharmaceuticals, Inc.
MDGL
$526.01M9.241.97M0%+$06.61
Monte Rosa Therapeutics, Inc.
GLUE
$34.66M8.084.92M0%+$00.44
DBV Technologies S.A.
DBVT
$10.95M7.5814.61M0%+$00.14
IGM Biosciences, Inc.
IGMS
$39.45M6.934.09M+10.76%+$3.83M0.5
Nurix Therapeutics, Inc.
NRIX
$57.07M6.553.88M0%+$00.72
Stoke Therapeutics, Inc.
STOK
$45.47M6.463.37M+65.92%+$18.07M0.57
Immatics N.V.
IMTX
$67.72M6.256.44M+10.35%+$6.35M0.85
Edgewise Therapeutics, Inc.
EWTX
$106.52M6.255.84M+87.61%+$49.75M1.34
Biomea Fusion, Inc.
BMEA
$31.53M5.872.11M0%+$00.4
Aerovate Therapeutics, Inc.
AVTE
$49.69M5.831.68M0%+$00.62
TScan Therapeutics, Inc.
TCRX
$22.11M5.272.78M0%+$00.28
Celcuity Inc.
CELC
$33.53M4.971.55M+189.92%+$21.97M0.42
BioCryst Pharmaceuticals, Inc.
BCRX
$51.44M4.9110.13M0%+$00.65
2seventy bio, Inc.
TSVT
$13.36M4.862.5M0%+$00.17
Revolution Medicines, Inc.
RVMD
$243.31M4.587.55M+46.63%+$77.37M3.06
Adaptimmune Therapeutics plc
ADAP
$17.04M4.2210.79M-1.66%-$287,970.800.21
Kiniksa Pharmaceuticals, Ltd.
KNSA
$55.43M3.962.81M0%+$00.7
Akero Therapeutics, Inc.
AKRO
$68.54M3.922.71M+14.56%+$8.71M0.86
Neurogene Inc.
NGNE
$23.21M3.51456,015+0.55%+$127,199.100.29
Immunocore Holdings plc
IMCR
$98.5M3.031.52M-39.89%-$65.35M1.24
Denali Therapeutics Inc.
DNLI
$76.57M2.623.73M+43.13%+$23.07M0.96
Taysha Gene Therapies, Inc.
TSHA
$11.49M2.144M0%+$00.14
Verve Therapeutics, Inc.
VERV
$22.46M2.021.69M0%+$00.28
Ultragenyx Pharmaceutical Inc.
RARE
$68.47M1.761.47M0%+$00.86
Fate Therapeutics, Inc.
FATE
$13.35M1.61.82MNew+$13.35M0.17
IDEAYA Biosciences, Inc.
IDYA
$46.61M1.41.06M0%+$00.59
Xenon Pharmaceuticals Inc.
XENE
$42.78M1.32993,6790%+$00.54
Roivant Sciences Ltd.
ROIV
$78.14M0.927.41M-2.36%-$1.89M0.98
Xencor, Inc.
XNCR
$12.07M0.89545,431+122.23%+$6.64M0.15
Cerevel Therapeutics Holdings, Inc.
CERE
$67.63M0.881.6M0%+$00.85
Relay Therapeutics, Inc.
RLAY
$9.63M0.871.16M0%+$00.12
BeiGene, Ltd.
BGNE
$1.65B0.7810.57M0%+$020.76
Krystal Biotech, Inc.
KRYS
$30.24M0.6169,9340%+$00.38
Celldex Therapeutics, Inc.
CLDX
$10.39M0.38247,6440%+$00.13
Immunovant, Inc.
IMVT
$13.73M0.29425,0090%+$00.17
argenx SE
ARGX
$59.54M0.25151,2150%+$00.75
Insmed Incorporated
INSM
$9.31M0.23343,0000%+$00.12